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time consuming and labor intensive by traditional bacteriological methods.
From our previous report [Yi et al., (1998) Use of Fluorescein Labelled
Antibody and Fluorescence Activated Cell Sorter for Rapid Identification of
Mycobacterium species. Biochem. Biophy. Res. Commu. 250: 403e408.], we
have used Flow Cytometry for rapid identification of Mycobacterium species.
However, identification of Mycobacterium to the species level can be
achieved only depending on the availability of species-specific antibody.
In this presentation, a rapid method involving intact cell mass spectrometry
(ICMS) is presented that shows promise for identification, typing and discrim-
ination of NTM species. In ICMS, cells from a bacterial colony are emulsified in a
chemical matrix, added to a sample probe, dried and analysed by matrix-
assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-
TOF-MS). This technique analyses proteins from intact and disrupted bacteria
yielding spectra consisting of 16 peaks from 5000 to 17500, which represent the
mass:charge (m:z) ratios. Each peak corresponds to a molecular fragment
released from the cell surface during laser desorption. Specimens can be
prepared in a few seconds from plate cultures and a spectrum can be obtained
within 10 min. Our results show that MALDI-TOF-MS is applicable for rapid
identification and differentiation of NTM, and thus shows its potential for
clinical NTM identification, or for epidemiological studies.SP 14-3
WHOLE-GENOME MAPPING: A NEW PARADIGM IN STRAIN-TYPING
TECHNOLOGY
Yangsoon Lee, MD, PhD. Department of Laboratory Medicine, Hanyang
Universisty College of Medicine, Hanyang University Seoul Hospital, Seoul,
Republic of Korea
Clinical microbiology is a discipline that focuses primarily on the rapidly
characterizing pathogen samples to direct the management of infected
individual patients and to monitor the epidemiology of infectious disease. A
brief overview of current practice through reviewing some recent articles
has focused on three essential tasks, and also outlined the potential of
sequencing technology to deliver the following key diagnostic information in
the clinical microbiology laboratory: identification of species, antimicrobial
resistance and presence of virulence determinants and strain typing to
detect outbreaks and support surveillance.
DNA sequencing is a powerful method to unravel genetic diversity of
microorganisms. Invention of next generation sequencing (NGS) which
enables massive and cost-effective DNA sequencing has revolutionized the
modern microbiology. Whole-genome sequencing yields all of the available
DNA information content on isolates in a single rapid step. The result
contains all of the data that are currently used for diagnostic and typing
needs, even though how to interpret the data is unknown sometimes.
However, the genome also includes vast amount of additional data that are
currently unavailable for routine processing, thus opening the prospect for
large-scale research into pathogen genotype-phenotype associations from
routinely collected data. High-throughput methods using NGS are evolutio-
nising bacterial genomics, providing sufficient resolution potentially to
determine which cases within temporo-spatial clusters are likely to be
related. With the advent of rapid sequencers, sources of outbreaks have
been identified in clinically relevant timescales, demonstrating the potential
of NGS to transform infection control practice. Genome sequences poten-
tially provide a high-resolution, accurate and reproducible means for
relating organisms. Sequencing can also rapidly provide a clear understand-
ing of the origins of a local outbreak. Examples of the effectiveness of whole
genome analysis for unraveling the origins and dispersal of pathogens at
regional and global scales have recently been published. Herein, the
recently published aritcles will be reviewed at this time.
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MOLECULAR DIAGNOSIS OF DRUG RESISTANCE IN MYCOBACTERIUM
TUBERCULOSIS
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Tuberculosis (TB) is caused by Mycobacterium tuberculosis complex (MTBC);
the disease is an important public health problem worldwide. Although the
global incidence of TB is decreasing, multidrug-resistant TB (MDR-TB) and
extensively drug-resistant TB (XDR-TB) are increasing. The conventional
method of drug susceptibility testing of MTBC takes 3 weeks. The aim of this
study was to detect point mutations in genes of MTBC conferring resistance
to the first and second line drugs [rifampin (RMP), isoniazid (INH), ethambutol
(EMB), streptomycin (SM), ofloxacin (OFX), kanamycin (KA), capreomycin
(CAP), and amikacin (AM)] in positive cultures of Mycobacterial Growth Indica-
tor Tube (MGIT). The method consisted of multiplex PCR (13 pairs of primers)
amplification of the relevant genes, followed by hybridization of the digoxige-
nin-labeled PCR products to probes immobilized on a nylon array. A total of
1426 positive MGIT cultures were analyzed. The sensitivities of the array
(based on patient number) were 91.7% (RMP), 88.9% (INH), 100% (EMB),
82.4% (SM), 100% (OFX), 100% (KA), 50.0% (CAP) and 100% (AM), respectively;
while the specificities were respectively 98.9% (RMP), 99.4% (INH), 99.5%
(EMB), 100% (SM), 100% (OFX), 100% (KA), 99.0% (CAP) and 99.5% (AM). The pos-
itive predictive values were 91.7% (RMP), 97.0% (INH), 92.9% (EMB), 100% (SM),
100% (OFX), 100% (KA), 33.3% (CAP) and 66.7% (AM), respectively; while the
negative predictive values were respectively 98.7% (RMP), 97.7% (INH), 100%
(EMB), 98.4% (SM), 100% (OFX), 100% (KA), 99.5% (CAP) and 100% (AM). In
conclusion, the array can effectively detect gene mutations causing drug
resistance to some important first and second line anti-TB antibiotics in posi-
tive MGIT cultures, except CAP, in a working day.SP 15-2
RAPID DIAGNOSTICS FOR SYPHILIS: AN OVERVIEW OF TEST
PERFORMANCE AND INTRODUCTION
Xiang-Sheng Chen a,*, Yue-Ping Yin a, Rosanna Peeling b. aNational Center
for Sexually Transmitted Disease Control, Chinese Academy of Medical
Sciences & Peking Union Medical College Institute of Dermatology, China;
bLondon School of Hygiene and Tropical Medicine, China
Syphilis remains a major public health problem in many low-income
countries that have limited capacity for laboratory testing, which tradition-
ally relies on use of a non-treponemal test for screening, followed by
confirmation of reactive sera using a treponemal test. However, traditional
tests are usually limited by needs of serum or plasma preparation,
equipment, skilled technician, and electricity. The development of rapid
diagnostics for syphilis (rapid syphilis tests) provides an opportunity to scale
up syphilis screening in many settings where traditional testing is unavai-
lable. Several formats of rapid syphilis tests including single rapid trepo-
nemal test, combined treponemal and non-treponemal test, and dual HIV-1/
2 and treponemal test are commercially available and more are in the
pipeline. Some of these tests have been independently evaluated for their
performance in terms of sensitivity and specificity at qualified laboratories
in multiple sites and showed high performance and favorable operational
characteristics. Based on evidence from evaluation studies, many countries
have changed their policies to adopt syphilis testing with rapid syphilis test
into their screening programmes to improve intervention of syphilis among
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syphilis tests are already changing patient management and there is a
promising pipeline of technologies that can strengthen syphilis testing and
management, but we still need further research on the use of rapid non-
treponemal titration tests to monitor response to treatment, and rapid
treponemal-specific IgM test for diagnosis of congenital infection, platform
to ensure access to syphilis testing and intervention, and enabling environ-
ment to accelerate introduction of these tests.SP 15-3
RAPID DETECTION OF MDROS FOR INFECTION CONTROL
Kyungwon Lee. Department of Laboratory Medicine and Research Institute
of Bacterial Resistance, Yonsei University College of Medicine, Seoul,
Republic of Korea
The global spread of multidrug-resistant organisms (MDROs) represents a
serious threat to public health and the economy. Therefore, optimal
treatment and prevention of MDRO infections are very important. Rapid
detection ofMDROswill help physiciansmake optimal treatment decisions and
help public health officials take action to prevent and control the infections
Presently, most detection methods take 24 to 72 hours from specimen
collection to results, with culture-based tests to determine antimicrobial
susceptibility adding additional a few days. On the other hand, molecular
methods offer rapid turnaround times (TATs), often <2 hours, and often
have higher sensitivity than culture methods. Recent detection technologies
using molecular methods are changing at rapid pace.
Among the MDROs, the most prevalent causes of healthcare-associated
infections are methicillin-resistant Staphylococcus aureus (MRSA), vancomy-
cin-resistant Enterococcus (VRE), and a wide variety of multidrug-resistant
gram-negative rods (MDR-GNRs).
MRSA is the organism for which there is the most experience with rapid
detection of carriage. Several types of molecular assays for detection of
MRSA directly from patient samples (e.g. nares) were introduced, and they
have been demonstrated to be more sensitive than culture-based methods.
VRE is the next most common target of tests for detection of MDRO carriage.
In contrast to screening for MRSA carriage, little enthusiasm has developed
for routine screening for the VRE carrier state.
Compared to MRSA and VRE, for which a single gene (mecA, vanA) provides a
gold standard forMDROdetection,MDR-GNRs present amuchgreater challenge,
because of their resistance mechanisms are multiple and highly complex. Most
laboratories that perform screening for MDR-GNRs carriage use one of a variety
of culture-based methods with analytic TATs of 24 hours or longer.
The development of rapid detection tests, combined with ongoing use of
culture-based tests to identify new resistance mechanisms, will greatly
advance detection, control, and prevention of MDROs such as MRSA, MDR-
GNRs, etc, and may help hospitals to improve infection control activities.SYMPOSIUM 16 (SP 16)
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WHO AND CDC GUIDELINES: KEY RECOMMENDATIONS
Joseph Solomkin. University of Cincinnati College of Medicine,
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SURGICAL UNIT-BASED SAFETY PROGRAM: TAPPING INTO THE WISDOM
OF FRONTLINE STAFF
Elizabeth Wick a, Deborah Hobson a, Sean Berenholtz a,*. aJohns Hopkins
Armstrong Institute for Patient Safety and Quality, United States
Background: Surgical site infections (SSI) are a common and costly problem,
prolonginghospitalization and increasing readmission.The globalburdenof pre-
ventable SSI continues to result in patient harmand increased health care costs.Study design:Wedesigned a study to evaluate the association between imple-
mentation of a surgery-based Comprehensive Unit-Based Safety Program
(CUSP) and postoperative SSI rates. CUSP builds on the principles of high reli-
ability organizations to educate frontline providers, identify and learn from
local defects, partner with a senior executive, and introduce teamwork and
communication tools to improve teamwork and safety culture. Pre- and
post-CUSP intervention SSI rates were collected using standardized definitions
provided by American College of Surgeons National Surgical Quality Improve-
ment Program (July 2009 to February 2014). The CUSP group met monthly and
consisted of a multidisciplinary team of front-line providers (eg, surgeons,
nurses, operating room technicians, and anesthesiologists) who were directly
involved in the care of colorectal surgery patients along with the support of
advanced practice providers, office coordinators, and hospital leadership.
Results: In the 12 months before implementation of the CUSP and interven-
tions, the mean SSI rate was 27.3% (76 of 278 patients). After commence-
ment of interventions, the rate was 18.2% (59 of 324 patients) for the
subsequent 12 monthsda 33.3% decrease (95% CI, 9e58%; p < 0.05) 1.
The SSI rate decreased further to less than 9% in 2014. The interventions
included standardization of skin preparation; administration of preoperative
chlorhexidine showers; selective elimination of mechanical bowel prepara-
tion; warming of patients in the preanesthesia area; adoption of enhanced
sterile techniques for skin and fascial closure; addressing previously unrec-
ognized lapses in antibiotic prophylaxis; and standardizing anesthetic man-
agement including pain control and fluid resuscitation.
Conclusions: Formation of small groups of front-line providers to address pa-
tient harm using local wisdom and existing evidence can improve patient
safety. We demonstrate a surgery-based CUSP intervention that was associ-
ated with a markedly decreased SSI rate in a high-risk population. We are
now implementing the multifaceted intervention, called the Surgical Unit-
Based Safety Program (SUSP) in 195 hospitals across 37 states.
1 Wick EC, et al. J Am Coll Surg 2012;215(2):193-200.SP 16-3
SMALL, SMALLER, SMALLEST! HOW TO (IF EVER) CLEAN AND STERILIZE
MICROSURGICAL INSTRUMENTS AND ROBOT ARMS?
Yu-Hui Chen. Chi Mei Hospital, Tainan, Taiwan
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SURGICAL CHECKLISTS: DO THEY IMPROVE PATIENT SAFETY?
Shu Lay Lee, Infection Control Manager. Thomson Medical Centre Ltd,
Singapore
Background: In the Operating Theatre besides focus on preventing hospital-
acquired infections, we must also prevent complications from surgical pro-
cedures. These complications can be infection related e.g. swabs left in
the abdomen. Since the introducing of safety checklist in 2013 we are
able to detect mishaps more efficiently.
One simple way to prevent mishaps is to use checklist to aid memory and
communication. Surgical checklists provide guidance and allow tracking of
completed tasks. Operation efficiency and team satisfaction are enhanced
by using surgical safety checklist.
Method: Meeting with relevant personnel to gather information on:
1. The types of operation performed in the hospital.
2. The types of mishaps / incidences from Operating Theatre were
reviewed over the last 2 years.
3. Brainstormed information needed in the Safety Checklist
4. Draft out Safety Checklist for review by personnel involved
TheNurse Clinician fromOperatingTheatre designed the checklist in 3 sessions:
Session ASign in e Before Induction of Anaesthesia
Session BTime Out e Before Skin Incision
Session CSign out e Before patient leave Operating Theatre
Result: The Surgical Safety Checklists do improve the communication
among surgical team. Surgical mishaps can be detected soon before
